nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Thiamylal—KCNJ8—coronary artery disease	0.0111	0.749	CrCbGaD
Methohexital—Hypotension—Clopidogrel—coronary artery disease	0.00283	0.00321	CcSEcCtD
Methohexital—Urticaria—Rosuvastatin—coronary artery disease	0.00282	0.0032	CcSEcCtD
Methohexital—Anaphylactic shock—Simvastatin—coronary artery disease	0.00281	0.00319	CcSEcCtD
Methohexital—Nausea—Penbutolol—coronary artery disease	0.00281	0.00319	CcSEcCtD
Methohexital—Erythema—Perindopril—coronary artery disease	0.00281	0.00319	CcSEcCtD
Methohexital—Abdominal pain—Rosuvastatin—coronary artery disease	0.00281	0.00318	CcSEcCtD
Methohexital—Pruritus—Ticagrelor—coronary artery disease	0.00279	0.00317	CcSEcCtD
Methohexital—Agitation—Trandolapril—coronary artery disease	0.00278	0.00316	CcSEcCtD
Methohexital—Agitation—Enalapril—coronary artery disease	0.00277	0.00314	CcSEcCtD
Methohexital—Anxiety—Valsartan—coronary artery disease	0.00276	0.00313	CcSEcCtD
Methohexital—Anxiety—Olmesartan—coronary artery disease	0.00275	0.00312	CcSEcCtD
Methohexital—Dyspnoea—Fenofibrate—coronary artery disease	0.00275	0.00312	CcSEcCtD
Methohexital—Urticaria—Acetylsalicylic acid—coronary artery disease	0.00274	0.00311	CcSEcCtD
Methohexital—Erythema—Furosemide—coronary artery disease	0.00273	0.0031	CcSEcCtD
Methohexital—Dyspnoea—Clopidogrel—coronary artery disease	0.0027	0.00306	CcSEcCtD
Methohexital—Hypotension—Eplerenone—coronary artery disease	0.0027	0.00306	CcSEcCtD
Methohexital—Dyspnoea—Lovastatin—coronary artery disease	0.00268	0.00304	CcSEcCtD
Methohexital—Anaphylactic shock—Valsartan—coronary artery disease	0.00266	0.00302	CcSEcCtD
Methohexital—Anxiety—Pravastatin—coronary artery disease	0.00265	0.003	CcSEcCtD
Methohexital—Anaphylactic shock—Olmesartan—coronary artery disease	0.00265	0.003	CcSEcCtD
Methohexital—Erythema—Losartan—coronary artery disease	0.00263	0.00299	CcSEcCtD
Methohexital—Dyspnoea—Ezetimibe—coronary artery disease	0.00263	0.00299	CcSEcCtD
Methohexital—Shock—Valsartan—coronary artery disease	0.00262	0.00297	CcSEcCtD
Methohexital—Shock—Olmesartan—coronary artery disease	0.0026	0.00295	CcSEcCtD
Methohexital—Anaphylactic shock—Niacin—coronary artery disease	0.00258	0.00293	CcSEcCtD
Methohexital—Tachycardia—Olmesartan—coronary artery disease	0.00258	0.00293	CcSEcCtD
Methohexital—Agitation—Perindopril—coronary artery disease	0.00258	0.00293	CcSEcCtD
Methohexital—Dyspnoea—Eplerenone—coronary artery disease	0.00258	0.00292	CcSEcCtD
Methohexital—Anxiety—Trandolapril—coronary artery disease	0.00257	0.00291	CcSEcCtD
Methohexital—Vomiting—Gemfibrozil—coronary artery disease	0.00257	0.00291	CcSEcCtD
Methohexital—Anaphylactic shock—Pravastatin—coronary artery disease	0.00254	0.00289	CcSEcCtD
Methohexital—Rhinitis—Timolol—coronary artery disease	0.00254	0.00288	CcSEcCtD
Methohexital—Shock—Niacin—coronary artery disease	0.00254	0.00288	CcSEcCtD
Methohexital—Headache—Gemfibrozil—coronary artery disease	0.00253	0.00287	CcSEcCtD
Methohexital—Anxiety—Telmisartan—coronary artery disease	0.00252	0.00286	CcSEcCtD
Methohexital—Tachycardia—Niacin—coronary artery disease	0.00252	0.00286	CcSEcCtD
Methohexital—Gastrointestinal pain—Fenofibrate—coronary artery disease	0.00252	0.00286	CcSEcCtD
Methohexital—Pruritus—Rosuvastatin—coronary artery disease	0.00251	0.00285	CcSEcCtD
Methohexital—Dyspnoea—Simvastatin—coronary artery disease	0.00251	0.00285	CcSEcCtD
Methohexital—Agitation—Furosemide—coronary artery disease	0.00251	0.00285	CcSEcCtD
Methohexital—Vomiting—Ticagrelor—coronary artery disease	0.00251	0.00285	CcSEcCtD
Methohexital—Hypotension—Valsartan—coronary artery disease	0.00248	0.00282	CcSEcCtD
Methohexital—Gastrointestinal pain—Clopidogrel—coronary artery disease	0.00248	0.00281	CcSEcCtD
Methohexital—Hypotension—Olmesartan—coronary artery disease	0.00247	0.0028	CcSEcCtD
Methohexital—Headache—Ticagrelor—coronary artery disease	0.00247	0.0028	CcSEcCtD
Methohexital—Anaphylactic shock—Enalapril—coronary artery disease	0.00246	0.00279	CcSEcCtD
Methohexital—Gastrointestinal pain—Lovastatin—coronary artery disease	0.00246	0.00279	CcSEcCtD
Methohexital—Urticaria—Fenofibrate—coronary artery disease	0.00245	0.00278	CcSEcCtD
Methohexital—Pruritus—Acetylsalicylic acid—coronary artery disease	0.00244	0.00277	CcSEcCtD
Methohexital—Abdominal pain—Fenofibrate—coronary artery disease	0.00244	0.00276	CcSEcCtD
Methohexital—Shock—Trandolapril—coronary artery disease	0.00243	0.00276	CcSEcCtD
Methohexital—Anaphylactic shock—Telmisartan—coronary artery disease	0.00243	0.00275	CcSEcCtD
Methohexital—Shock—Enalapril—coronary artery disease	0.00242	0.00275	CcSEcCtD
Methohexital—Agitation—Losartan—coronary artery disease	0.00242	0.00275	CcSEcCtD
Methohexital—Hypotension—Niacin—coronary artery disease	0.00242	0.00274	CcSEcCtD
Methohexital—Gastrointestinal pain—Ezetimibe—coronary artery disease	0.00241	0.00274	CcSEcCtD
Methohexital—Tachycardia—Trandolapril—coronary artery disease	0.00241	0.00274	CcSEcCtD
Methohexital—Urticaria—Clopidogrel—coronary artery disease	0.00241	0.00273	CcSEcCtD
Methohexital—Tachycardia—Enalapril—coronary artery disease	0.0024	0.00272	CcSEcCtD
Methohexital—Nausea—Gemfibrozil—coronary artery disease	0.0024	0.00272	CcSEcCtD
Methohexital—Abdominal pain—Clopidogrel—coronary artery disease	0.00239	0.00272	CcSEcCtD
Methohexital—Urticaria—Lovastatin—coronary artery disease	0.00239	0.00271	CcSEcCtD
Methohexital—Shock—Telmisartan—coronary artery disease	0.00239	0.00271	CcSEcCtD
Methohexital—Anxiety—Perindopril—coronary artery disease	0.00238	0.0027	CcSEcCtD
Methohexital—Abdominal pain—Lovastatin—coronary artery disease	0.00238	0.0027	CcSEcCtD
Methohexital—Dyspnoea—Valsartan—coronary artery disease	0.00237	0.00269	CcSEcCtD
Methohexital—Tachycardia—Telmisartan—coronary artery disease	0.00237	0.00269	CcSEcCtD
Methohexital—Gastrointestinal pain—Eplerenone—coronary artery disease	0.00236	0.00268	CcSEcCtD
Methohexital—Anaphylactic shock—Captopril—coronary artery disease	0.00236	0.00268	CcSEcCtD
Methohexital—Rhinitis—Lisinopril—coronary artery disease	0.00236	0.00268	CcSEcCtD
Methohexital—Urticaria—Ezetimibe—coronary artery disease	0.00234	0.00266	CcSEcCtD
Methohexital—Nausea—Ticagrelor—coronary artery disease	0.00234	0.00266	CcSEcCtD
Methohexital—Abdominal pain—Ezetimibe—coronary artery disease	0.00233	0.00265	CcSEcCtD
Methohexital—Shock—Captopril—coronary artery disease	0.00232	0.00263	CcSEcCtD
Methohexital—Hypotension—Trandolapril—coronary artery disease	0.00231	0.00262	CcSEcCtD
Methohexital—Dyspnoea—Niacin—coronary artery disease	0.0023	0.00261	CcSEcCtD
Methohexital—Tachycardia—Captopril—coronary artery disease	0.0023	0.00261	CcSEcCtD
Methohexital—Gastrointestinal pain—Simvastatin—coronary artery disease	0.0023	0.00261	CcSEcCtD
Methohexital—Hypotension—Enalapril—coronary artery disease	0.0023	0.00261	CcSEcCtD
Methohexital—Anaphylactic shock—Perindopril—coronary artery disease	0.00229	0.0026	CcSEcCtD
Methohexital—Abdominal pain—Eplerenone—coronary artery disease	0.00228	0.00259	CcSEcCtD
Methohexital—Dyspnoea—Pravastatin—coronary artery disease	0.00227	0.00257	CcSEcCtD
Methohexital—Hypotension—Telmisartan—coronary artery disease	0.00227	0.00257	CcSEcCtD
Methohexital—Erythema—Ramipril—coronary artery disease	0.00226	0.00256	CcSEcCtD
Methohexital—Shock—Perindopril—coronary artery disease	0.00225	0.00256	CcSEcCtD
Methohexital—Tachycardia—Perindopril—coronary artery disease	0.00224	0.00254	CcSEcCtD
Methohexital—Urticaria—Simvastatin—coronary artery disease	0.00224	0.00254	CcSEcCtD
Methohexital—Anxiety—Losartan—coronary artery disease	0.00223	0.00254	CcSEcCtD
Methohexital—Anaphylactic shock—Furosemide—coronary artery disease	0.00223	0.00253	CcSEcCtD
Methohexital—Abdominal pain—Simvastatin—coronary artery disease	0.00223	0.00252	CcSEcCtD
Methohexital—Headache—Rosuvastatin—coronary artery disease	0.00222	0.00252	CcSEcCtD
Methohexital—Erythema—Timolol—coronary artery disease	0.00221	0.0025	CcSEcCtD
Methohexital—Hypotension—Captopril—coronary artery disease	0.00221	0.0025	CcSEcCtD
Methohexital—Dyspnoea—Trandolapril—coronary artery disease	0.0022	0.0025	CcSEcCtD
Methohexital—Dyspnoea—Enalapril—coronary artery disease	0.00219	0.00249	CcSEcCtD
Methohexital—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00219	0.00249	CcSEcCtD
Methohexital—Shock—Furosemide—coronary artery disease	0.00219	0.00249	CcSEcCtD
Methohexital—Pruritus—Fenofibrate—coronary artery disease	0.00218	0.00247	CcSEcCtD
Methohexital—Gastrointestinal pain—Valsartan—coronary artery disease	0.00217	0.00247	CcSEcCtD
Methohexital—Dyspnoea—Telmisartan—coronary artery disease	0.00216	0.00246	CcSEcCtD
Methohexital—Gastrointestinal pain—Olmesartan—coronary artery disease	0.00216	0.00245	CcSEcCtD
Methohexital—Anaphylactic shock—Losartan—coronary artery disease	0.00215	0.00244	CcSEcCtD
Methohexital—Pruritus—Clopidogrel—coronary artery disease	0.00214	0.00243	CcSEcCtD
Methohexital—Hypotension—Perindopril—coronary artery disease	0.00214	0.00243	CcSEcCtD
Methohexital—Pruritus—Lovastatin—coronary artery disease	0.00213	0.00242	CcSEcCtD
Methohexital—Shock—Losartan—coronary artery disease	0.00212	0.0024	CcSEcCtD
Methohexital—Gastrointestinal pain—Niacin—coronary artery disease	0.00211	0.0024	CcSEcCtD
Methohexital—Urticaria—Valsartan—coronary artery disease	0.00211	0.0024	CcSEcCtD
Methohexital—Nausea—Rosuvastatin—coronary artery disease	0.00211	0.00239	CcSEcCtD
Methohexital—Dyspnoea—Captopril—coronary artery disease	0.0021	0.00239	CcSEcCtD
Methohexital—Urticaria—Olmesartan—coronary artery disease	0.0021	0.00238	CcSEcCtD
Methohexital—Abdominal pain—Valsartan—coronary artery disease	0.0021	0.00238	CcSEcCtD
Methohexital—GABRB3—GABA receptor activation—KCNJ2—coronary artery disease	0.0021	0.0203	CbGpPWpGaD
Methohexital—Tachycardia—Losartan—coronary artery disease	0.0021	0.00238	CcSEcCtD
Methohexital—Abdominal pain—Olmesartan—coronary artery disease	0.00209	0.00237	CcSEcCtD
Methohexital—Pruritus—Ezetimibe—coronary artery disease	0.00209	0.00237	CcSEcCtD
Methohexital—Hypotension—Furosemide—coronary artery disease	0.00208	0.00236	CcSEcCtD
Methohexital—Gastrointestinal pain—Pravastatin—coronary artery disease	0.00208	0.00236	CcSEcCtD
Methohexital—Agitation—Ramipril—coronary artery disease	0.00208	0.00235	CcSEcCtD
Methohexital—GABRG2—GABA receptor activation—KCNJ2—coronary artery disease	0.00206	0.0199	CbGpPWpGaD
Methohexital—Urticaria—Niacin—coronary artery disease	0.00205	0.00233	CcSEcCtD
Methohexital—Nausea—Acetylsalicylic acid—coronary artery disease	0.00205	0.00232	CcSEcCtD
Methohexital—Erythema—Lisinopril—coronary artery disease	0.00205	0.00232	CcSEcCtD
Methohexital—Pruritus—Eplerenone—coronary artery disease	0.00204	0.00232	CcSEcCtD
Methohexital—Dyspnoea—Perindopril—coronary artery disease	0.00204	0.00232	CcSEcCtD
Methohexital—Abdominal pain—Niacin—coronary artery disease	0.00204	0.00232	CcSEcCtD
Methohexital—Urticaria—Pravastatin—coronary artery disease	0.00202	0.00229	CcSEcCtD
Methohexital—Gastrointestinal pain—Trandolapril—coronary artery disease	0.00202	0.00229	CcSEcCtD
Methohexital—Gastrointestinal pain—Enalapril—coronary artery disease	0.00201	0.00228	CcSEcCtD
Methohexital—Abdominal pain—Pravastatin—coronary artery disease	0.00201	0.00228	CcSEcCtD
Methohexital—Hypotension—Losartan—coronary artery disease	0.00201	0.00228	CcSEcCtD
Methohexital—Pruritus—Simvastatin—coronary artery disease	0.00199	0.00226	CcSEcCtD
Methohexital—Gastrointestinal pain—Telmisartan—coronary artery disease	0.00199	0.00225	CcSEcCtD
Methohexital—Urticaria—Trandolapril—coronary artery disease	0.00196	0.00223	CcSEcCtD
Methohexital—Methylphenobarbital—CYP2C19—coronary artery disease	0.00196	0.132	CrCbGaD
Methohexital—Vomiting—Fenofibrate—coronary artery disease	0.00196	0.00222	CcSEcCtD
Methohexital—Convulsion—Ramipril—coronary artery disease	0.00196	0.00222	CcSEcCtD
Methohexital—Urticaria—Enalapril—coronary artery disease	0.00196	0.00222	CcSEcCtD
Methohexital—Abdominal pain—Trandolapril—coronary artery disease	0.00195	0.00222	CcSEcCtD
Methohexital—Abdominal pain—Enalapril—coronary artery disease	0.00195	0.00221	CcSEcCtD
Methohexital—Headache—Fenofibrate—coronary artery disease	0.00193	0.00219	CcSEcCtD
Methohexital—Gastrointestinal pain—Captopril—coronary artery disease	0.00193	0.00219	CcSEcCtD
Methohexital—Urticaria—Telmisartan—coronary artery disease	0.00193	0.00219	CcSEcCtD
Methohexital—Vomiting—Clopidogrel—coronary artery disease	0.00193	0.00218	CcSEcCtD
Methohexital—Abdominal pain—Telmisartan—coronary artery disease	0.00192	0.00218	CcSEcCtD
Methohexital—Dyspnoea—Losartan—coronary artery disease	0.00192	0.00217	CcSEcCtD
Methohexital—Anxiety—Ramipril—coronary artery disease	0.00192	0.00217	CcSEcCtD
Methohexital—Vomiting—Lovastatin—coronary artery disease	0.00191	0.00217	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00191	0.0184	CbGpPWpGaD
Methohexital—Headache—Clopidogrel—coronary artery disease	0.0019	0.00215	CcSEcCtD
Methohexital—Headache—Lovastatin—coronary artery disease	0.00189	0.00214	CcSEcCtD
Methohexital—Pruritus—Valsartan—coronary artery disease	0.00188	0.00213	CcSEcCtD
Methohexital—Vomiting—Ezetimibe—coronary artery disease	0.00188	0.00213	CcSEcCtD
Methohexital—Gastrointestinal pain—Perindopril—coronary artery disease	0.00187	0.00213	CcSEcCtD
Methohexital—Anxiety—Timolol—coronary artery disease	0.00187	0.00213	CcSEcCtD
Methohexital—Pruritus—Olmesartan—coronary artery disease	0.00187	0.00212	CcSEcCtD
Methohexital—Abdominal pain—Captopril—coronary artery disease	0.00187	0.00212	CcSEcCtD
Methohexital—Headache—Ezetimibe—coronary artery disease	0.00185	0.0021	CcSEcCtD
Methohexital—Anaphylactic shock—Ramipril—coronary artery disease	0.00184	0.00209	CcSEcCtD
Methohexital—Vomiting—Eplerenone—coronary artery disease	0.00184	0.00208	CcSEcCtD
Methohexital—Nausea—Fenofibrate—coronary artery disease	0.00183	0.00208	CcSEcCtD
Methohexital—Pruritus—Niacin—coronary artery disease	0.00183	0.00207	CcSEcCtD
Methohexital—Gastrointestinal pain—Furosemide—coronary artery disease	0.00182	0.00207	CcSEcCtD
Methohexital—Urticaria—Perindopril—coronary artery disease	0.00182	0.00207	CcSEcCtD
Methohexital—Shock—Ramipril—coronary artery disease	0.00181	0.00206	CcSEcCtD
Methohexital—Abdominal pain—Perindopril—coronary artery disease	0.00181	0.00206	CcSEcCtD
Methohexital—Headache—Eplerenone—coronary artery disease	0.00181	0.00205	CcSEcCtD
Methohexital—GABRA1—GABA receptor activation—KCNJ2—coronary artery disease	0.0018	0.0174	CbGpPWpGaD
Methohexital—Anaphylactic shock—Timolol—coronary artery disease	0.0018	0.00204	CcSEcCtD
Methohexital—Pruritus—Pravastatin—coronary artery disease	0.0018	0.00204	CcSEcCtD
Methohexital—Nausea—Clopidogrel—coronary artery disease	0.0018	0.00204	CcSEcCtD
Methohexital—Tachycardia—Ramipril—coronary artery disease	0.0018	0.00204	CcSEcCtD
Methohexital—Vomiting—Simvastatin—coronary artery disease	0.00179	0.00203	CcSEcCtD
Methohexital—Nausea—Lovastatin—coronary artery disease	0.00179	0.00203	CcSEcCtD
Methohexital—Shock—Timolol—coronary artery disease	0.00177	0.00201	CcSEcCtD
Methohexital—Urticaria—Furosemide—coronary artery disease	0.00177	0.00201	CcSEcCtD
Methohexital—Headache—Simvastatin—coronary artery disease	0.00176	0.002	CcSEcCtD
Methohexital—Pentobarbital—CYP2C19—coronary artery disease	0.00176	0.119	CrCbGaD
Methohexital—Abdominal pain—Furosemide—coronary artery disease	0.00176	0.002	CcSEcCtD
Methohexital—Gastrointestinal pain—Losartan—coronary artery disease	0.00176	0.00199	CcSEcCtD
Methohexital—Nausea—Ezetimibe—coronary artery disease	0.00175	0.00199	CcSEcCtD
Methohexital—Pruritus—Trandolapril—coronary artery disease	0.00175	0.00198	CcSEcCtD
Methohexital—Pruritus—Enalapril—coronary artery disease	0.00174	0.00198	CcSEcCtD
Methohexital—Anxiety—Lisinopril—coronary artery disease	0.00174	0.00197	CcSEcCtD
Methohexital—Hypotension—Ramipril—coronary artery disease	0.00172	0.00195	CcSEcCtD
Methohexital—Pruritus—Telmisartan—coronary artery disease	0.00172	0.00195	CcSEcCtD
Methohexital—Nausea—Eplerenone—coronary artery disease	0.00172	0.00195	CcSEcCtD
Methohexital—Urticaria—Losartan—coronary artery disease	0.00171	0.00194	CcSEcCtD
Methohexital—Abdominal pain—Losartan—coronary artery disease	0.0017	0.00193	CcSEcCtD
Methohexital—Vomiting—Valsartan—coronary artery disease	0.00169	0.00192	CcSEcCtD
Methohexital—Hypotension—Timolol—coronary artery disease	0.00168	0.00191	CcSEcCtD
Methohexital—Vomiting—Olmesartan—coronary artery disease	0.00168	0.00191	CcSEcCtD
Methohexital—Nausea—Simvastatin—coronary artery disease	0.00167	0.0019	CcSEcCtD
Methohexital—Anaphylactic shock—Lisinopril—coronary artery disease	0.00167	0.0019	CcSEcCtD
Methohexital—Pruritus—Captopril—coronary artery disease	0.00167	0.00189	CcSEcCtD
Methohexital—Headache—Valsartan—coronary artery disease	0.00167	0.00189	CcSEcCtD
Methohexital—Headache—Olmesartan—coronary artery disease	0.00166	0.00188	CcSEcCtD
Methohexital—Shock—Lisinopril—coronary artery disease	0.00164	0.00187	CcSEcCtD
Methohexital—GABRB3—BDNF signaling pathway—SORT1—coronary artery disease	0.00164	0.0159	CbGpPWpGaD
Methohexital—Dyspnoea—Ramipril—coronary artery disease	0.00164	0.00186	CcSEcCtD
Methohexital—Vomiting—Niacin—coronary artery disease	0.00164	0.00186	CcSEcCtD
Methohexital—Tachycardia—Lisinopril—coronary artery disease	0.00163	0.00185	CcSEcCtD
Methohexital—Pruritus—Perindopril—coronary artery disease	0.00162	0.00184	CcSEcCtD
Methohexital—Headache—Niacin—coronary artery disease	0.00162	0.00184	CcSEcCtD
Methohexital—Vomiting—Pravastatin—coronary artery disease	0.00162	0.00184	CcSEcCtD
Methohexital—Dyspnoea—Timolol—coronary artery disease	0.00161	0.00182	CcSEcCtD
Methohexital—Headache—Pravastatin—coronary artery disease	0.00159	0.00181	CcSEcCtD
Methohexital—Nausea—Valsartan—coronary artery disease	0.00158	0.00179	CcSEcCtD
Methohexital—Pruritus—Furosemide—coronary artery disease	0.00158	0.00179	CcSEcCtD
Methohexital—Nausea—Olmesartan—coronary artery disease	0.00157	0.00178	CcSEcCtD
Methohexital—Vomiting—Trandolapril—coronary artery disease	0.00157	0.00178	CcSEcCtD
Methohexital—Vomiting—Enalapril—coronary artery disease	0.00156	0.00178	CcSEcCtD
Methohexital—Hypotension—Lisinopril—coronary artery disease	0.00156	0.00177	CcSEcCtD
Methohexital—Headache—Trandolapril—coronary artery disease	0.00155	0.00176	CcSEcCtD
Methohexital—Vomiting—Telmisartan—coronary artery disease	0.00154	0.00175	CcSEcCtD
Methohexital—Headache—Enalapril—coronary artery disease	0.00154	0.00175	CcSEcCtD
Methohexital—Nausea—Niacin—coronary artery disease	0.00154	0.00174	CcSEcCtD
Methohexital—Pruritus—Losartan—coronary artery disease	0.00152	0.00173	CcSEcCtD
Methohexital—Headache—Telmisartan—coronary artery disease	0.00152	0.00173	CcSEcCtD
Methohexital—Nausea—Pravastatin—coronary artery disease	0.00151	0.00171	CcSEcCtD
Methohexital—Gastrointestinal pain—Ramipril—coronary artery disease	0.00151	0.00171	CcSEcCtD
Methohexital—Vomiting—Captopril—coronary artery disease	0.0015	0.0017	CcSEcCtD
Methohexital—Dyspnoea—Lisinopril—coronary artery disease	0.00149	0.00169	CcSEcCtD
Methohexital—Headache—Captopril—coronary artery disease	0.00148	0.00168	CcSEcCtD
Methohexital—Gastrointestinal pain—Timolol—coronary artery disease	0.00147	0.00167	CcSEcCtD
Methohexital—Nausea—Trandolapril—coronary artery disease	0.00147	0.00167	CcSEcCtD
Methohexital—Urticaria—Ramipril—coronary artery disease	0.00146	0.00166	CcSEcCtD
Methohexital—Nausea—Enalapril—coronary artery disease	0.00146	0.00166	CcSEcCtD
Methohexital—Vomiting—Perindopril—coronary artery disease	0.00146	0.00165	CcSEcCtD
Methohexital—Abdominal pain—Ramipril—coronary artery disease	0.00146	0.00165	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00145	0.014	CbGpPWpGaD
Methohexital—Nausea—Telmisartan—coronary artery disease	0.00144	0.00164	CcSEcCtD
Methohexital—Headache—Perindopril—coronary artery disease	0.00144	0.00163	CcSEcCtD
Methohexital—Urticaria—Timolol—coronary artery disease	0.00143	0.00162	CcSEcCtD
Methohexital—Abdominal pain—Timolol—coronary artery disease	0.00142	0.00162	CcSEcCtD
Methohexital—Vomiting—Furosemide—coronary artery disease	0.00142	0.00161	CcSEcCtD
Methohexital—GABRB3—Orphan transporters—COX5B—coronary artery disease	0.00141	0.0136	CbGpPWpGaD
Methohexital—Nausea—Captopril—coronary artery disease	0.0014	0.00159	CcSEcCtD
Methohexital—Headache—Furosemide—coronary artery disease	0.0014	0.00158	CcSEcCtD
Methohexital—GABRB3—Ion channel transport—FXYD1—coronary artery disease	0.00139	0.0134	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—COX5B—coronary artery disease	0.00139	0.0134	CbGpPWpGaD
Methohexital—Gastrointestinal pain—Lisinopril—coronary artery disease	0.00137	0.00155	CcSEcCtD
Methohexital—Vomiting—Losartan—coronary artery disease	0.00137	0.00155	CcSEcCtD
Methohexital—GABRG2—Ion channel transport—FXYD1—coronary artery disease	0.00137	0.0132	CbGpPWpGaD
Methohexital—Nausea—Perindopril—coronary artery disease	0.00136	0.00154	CcSEcCtD
Methohexital—Headache—Losartan—coronary artery disease	0.00135	0.00153	CcSEcCtD
Methohexital—Urticaria—Lisinopril—coronary artery disease	0.00133	0.00151	CcSEcCtD
Methohexital—Nausea—Furosemide—coronary artery disease	0.00132	0.0015	CcSEcCtD
Methohexital—Abdominal pain—Lisinopril—coronary artery disease	0.00132	0.0015	CcSEcCtD
Methohexital—Pruritus—Ramipril—coronary artery disease	0.0013	0.00148	CcSEcCtD
Methohexital—Nausea—Losartan—coronary artery disease	0.00128	0.00145	CcSEcCtD
Methohexital—Pruritus—Timolol—coronary artery disease	0.00127	0.00145	CcSEcCtD
Methohexital—GABRB3—Ion channel transport—ATP1A1—coronary artery disease	0.00124	0.012	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP1A1—coronary artery disease	0.00122	0.0117	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—COX5B—coronary artery disease	0.00121	0.0117	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—FXYD1—coronary artery disease	0.00119	0.0115	CbGpPWpGaD
Methohexital—Pruritus—Lisinopril—coronary artery disease	0.00118	0.00134	CcSEcCtD
Methohexital—Vomiting—Ramipril—coronary artery disease	0.00117	0.00133	CcSEcCtD
Methohexital—Headache—Ramipril—coronary artery disease	0.00115	0.00131	CcSEcCtD
Methohexital—Vomiting—Timolol—coronary artery disease	0.00115	0.0013	CcSEcCtD
Methohexital—Headache—Timolol—coronary artery disease	0.00113	0.00128	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.0011	0.0106	CbGpPWpGaD
Methohexital—Nausea—Ramipril—coronary artery disease	0.00109	0.00124	CcSEcCtD
Methohexital—GABRB3—BDNF signaling pathway—EGR2—coronary artery disease	0.00109	0.0105	CbGpPWpGaD
Methohexital—Nausea—Timolol—coronary artery disease	0.00107	0.00121	CcSEcCtD
Methohexital—GABRA1—Ion channel transport—ATP1A1—coronary artery disease	0.00106	0.0103	CbGpPWpGaD
Methohexital—Vomiting—Lisinopril—coronary artery disease	0.00106	0.00121	CcSEcCtD
Methohexital—Headache—Lisinopril—coronary artery disease	0.00105	0.00119	CcSEcCtD
Methohexital—GABRB3—BDNF signaling pathway—YBX1—coronary artery disease	0.00103	0.00996	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.001	0.00968	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.001	0.00968	CbGpPWpGaD
Methohexital—Nausea—Lisinopril—coronary artery disease	0.000993	0.00113	CcSEcCtD
Methohexital—GABRB3—Ion channel transport—RYR2—coronary artery disease	0.000991	0.00956	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—RYR2—coronary artery disease	0.000973	0.00939	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000966	0.00932	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—PLN—coronary artery disease	0.000964	0.0093	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000948	0.00915	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—PLN—coronary artery disease	0.000947	0.00913	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.000877	0.00846	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP4A—coronary artery disease	0.000859	0.00829	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—RYR2—coronary artery disease	0.000851	0.00821	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP4A—coronary artery disease	0.000844	0.00814	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.000831	0.00802	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ2—coronary artery disease	0.000829	0.008	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—PLN—coronary artery disease	0.000827	0.00798	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MEF2A—coronary artery disease	0.000803	0.00775	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP2B1—coronary artery disease	0.000762	0.00735	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP2B1—coronary artery disease	0.000748	0.00722	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—CETP—coronary artery disease	0.000742	0.00716	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000739	0.00713	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP4A—coronary artery disease	0.000737	0.00712	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—KCNJ8—coronary artery disease	0.000734	0.00708	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—CETP—coronary artery disease	0.000729	0.00703	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000726	0.007	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000726	0.007	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—KCNJ8—coronary artery disease	0.000721	0.00695	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000713	0.00688	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.000707	0.00682	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP2B1—coronary artery disease	0.000654	0.00631	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—PLAT—coronary artery disease	0.000654	0.00631	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—PLAT—coronary artery disease	0.000642	0.0062	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—CETP—coronary artery disease	0.000637	0.00615	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB3—coronary artery disease	0.000634	0.00612	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—KCNJ8—coronary artery disease	0.00063	0.00608	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CDH2—coronary artery disease	0.000625	0.00603	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—KCNJ2—coronary artery disease	0.000623	0.00601	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000615	0.00593	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000582	0.00561	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000569	0.00549	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000565	0.00545	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—PLAT—coronary artery disease	0.000561	0.00542	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000559	0.00539	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—KCNJ2—coronary artery disease	0.000556	0.00537	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—PLG—coronary artery disease	0.000556	0.00537	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000556	0.00536	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—KCNJ2—coronary artery disease	0.000546	0.00527	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—PLG—coronary artery disease	0.000546	0.00527	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000546	0.00527	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP2A2—coronary artery disease	0.00054	0.00521	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP2A2—coronary artery disease	0.00053	0.00511	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000519	0.005	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—APOB—coronary artery disease	0.000492	0.00474	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—coronary artery disease	0.000488	0.00471	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000486	0.00469	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000484	0.00467	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—APOB—coronary artery disease	0.000483	0.00466	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000478	0.00461	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—KCNJ2—coronary artery disease	0.000477	0.00461	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—PLG—coronary artery disease	0.000477	0.00461	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—PLCB3—coronary artery disease	0.000477	0.0046	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000475	0.00459	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000468	0.00451	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP2A2—coronary artery disease	0.000463	0.00447	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000459	0.00443	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000431	0.00416	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000431	0.00416	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000428	0.00413	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—PLCB3—coronary artery disease	0.000426	0.00411	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000424	0.00409	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000424	0.00409	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—APOB—coronary artery disease	0.000422	0.00407	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.00042	0.00405	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—PLCB3—coronary artery disease	0.000418	0.00403	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—coronary artery disease	0.000418	0.00403	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000415	0.00401	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000415	0.004	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000412	0.00397	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000404	0.0039	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—ALDH2—coronary artery disease	0.000401	0.00387	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—STAT5A—coronary artery disease	0.000392	0.00378	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000384	0.00371	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.00037	0.00357	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.00037	0.00357	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—CAMK2D—coronary artery disease	0.000367	0.00354	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000366	0.00353	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—PLCB3—coronary artery disease	0.000365	0.00353	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000359	0.00347	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MEF2C—coronary artery disease	0.000359	0.00346	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—RPS6KB1—coronary artery disease	0.000359	0.00346	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—ALDH2—coronary artery disease	0.000358	0.00346	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000353	0.00341	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—ALDH2—coronary artery disease	0.000352	0.0034	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000345	0.00333	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000345	0.00333	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000342	0.0033	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PPP2CA—coronary artery disease	0.000339	0.00328	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000339	0.00327	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000339	0.00327	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000335	0.00324	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PRKCD—coronary artery disease	0.000333	0.00322	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000329	0.00318	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—CAMK2D—coronary artery disease	0.000328	0.00316	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—CAMK2D—coronary artery disease	0.000322	0.00311	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.00032	0.00309	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—PLCB1—coronary artery disease	0.000314	0.00303	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000312	0.00301	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—ALDH2—coronary artery disease	0.000308	0.00297	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000306	0.00296	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000299	0.00289	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000299	0.00289	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000298	0.00288	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000297	0.00286	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000296	0.00286	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000296	0.00286	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAPK14—coronary artery disease	0.000295	0.00285	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000294	0.00283	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000294	0.00283	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000289	0.00279	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000288	0.00278	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—NFKBIA—coronary artery disease	0.000283	0.00273	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—CAMK2D—coronary artery disease	0.000281	0.00271	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—PLCB1—coronary artery disease	0.00028	0.0027	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—PLCB1—coronary artery disease	0.000275	0.00266	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000268	0.00258	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000266	0.00257	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000265	0.00256	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000265	0.00256	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—GSK3B—coronary artery disease	0.000263	0.00253	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000263	0.00253	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000262	0.00252	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CREB1—coronary artery disease	0.000261	0.00251	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.00026	0.00251	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.00026	0.00251	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000257	0.00248	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000257	0.00248	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.00025	0.00241	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000245	0.00236	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000245	0.00236	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000245	0.00236	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—PLCB1—coronary artery disease	0.000241	0.00232	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00024	0.00232	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00024	0.00232	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00024	0.00232	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	0.000229	0.00221	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000228	0.0022	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000228	0.0022	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—JAK2—coronary artery disease	0.000221	0.00213	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00021	0.00203	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00021	0.00203	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00021	0.00203	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.00021	0.00202	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000205	0.00197	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.0002	0.00193	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000197	0.0019	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CASP3—coronary artery disease	0.000193	0.00186	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000188	0.00181	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000184	0.00178	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000183	0.00177	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000181	0.00175	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.00018	0.00174	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000178	0.00172	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—CREB1—coronary artery disease	0.000172	0.00166	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000172	0.00166	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000169	0.00163	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000162	0.00157	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000161	0.00156	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.00016	0.00154	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000157	0.00152	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000157	0.00151	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000156	0.0015	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000155	0.0015	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000155	0.0015	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—CREB1—coronary artery disease	0.000153	0.00148	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—CREB1—coronary artery disease	0.000151	0.00145	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000151	0.00145	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000148	0.00143	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000147	0.00142	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—MAPK1—coronary artery disease	0.000147	0.00142	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000137	0.00132	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000136	0.00131	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000133	0.00129	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000132	0.00127	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—CREB1—coronary artery disease	0.000132	0.00127	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	0.000129	0.00125	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000125	0.00121	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000123	0.00119	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—APOB—coronary artery disease	0.00012	0.00116	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000118	0.00114	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000117	0.00112	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000113	0.00109	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000113	0.00109	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	0.000111	0.00107	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000108	0.00104	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—AKT1—coronary artery disease	0.000104	0.00101	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000103	0.000994	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	9.72e-05	0.000938	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—APOA1—coronary artery disease	9.49e-05	0.000916	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—APOA1—coronary artery disease	9.32e-05	0.0009	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL6—coronary artery disease	9.11e-05	0.000879	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—MAPK1—coronary artery disease	8.68e-05	0.000837	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—MAPK1—coronary artery disease	8.52e-05	0.000822	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.15e-05	0.000786	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ALB—coronary artery disease	7.52e-05	0.000726	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—MAPK1—coronary artery disease	7.45e-05	0.000719	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ALB—coronary artery disease	7.39e-05	0.000713	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ALB—coronary artery disease	6.46e-05	0.000623	CbGpPWpGaD
